 CORAL GABLES, Fla., Aug. 16, 2021 GLOBE NEWSWIRE -- Catalyst Pharmaceuticals, Inc. Catalyst Nasdaq: CPRX, a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing and commercializing novel high-quality medicines for patients living with rare diseases, today announced that Mary Coleman has been appointed to the newly created position of Vice President, Head of Investor Relations. This position will report to the Chief Executive Officer of Catalyst. 